| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2022 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.55M | 22.90M | 22.89M | 20.64M | 16.96M | 13.10M |
| Gross Profit | 9.04M | 15.89M | 16.21M | 12.89M | 10.37M | 7.65M |
| EBITDA | 5.30M | 3.75M | 6.04M | 8.12M | 4.32M | 1.96M |
| Net Income | 1.13M | -18.00K | 2.06M | 4.81M | 1.24M | 1.82M |
Balance Sheet | ||||||
| Total Assets | 64.18M | 63.19M | 69.11M | 60.47M | 59.33M | 65.24M |
| Cash, Cash Equivalents and Short-Term Investments | 10.68M | 9.92M | 18.21M | 22.26M | 25.04M | 32.20M |
| Total Debt | 1.99M | 2.26M | 856.00K | 1.05M | 468.00K | 727.00K |
| Total Liabilities | 14.82M | 14.18M | 18.04M | 9.71M | 9.48M | 11.80M |
| Stockholders Equity | 49.35M | 49.01M | 51.08M | 50.75M | 49.85M | 53.45M |
Cash Flow | ||||||
| Free Cash Flow | 1.48M | -1.75M | -53.00K | 182.00K | -616.00K | 223.00K |
| Operating Cash Flow | 2.27M | 3.09M | 5.04M | 5.67M | 4.02M | 7.88M |
| Investing Cash Flow | -147.00K | -3.39M | -10.85M | 1.75M | 1.81M | 15.72M |
| Financing Cash Flow | -2.46M | -3.09M | -3.88M | -5.56M | -8.92M | -10.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £630.55M | 24.33 | 8.49% | 2.09% | 0.49% | 61.73% | |
75 Outperform | £444.28M | 44.40 | 55.98% | ― | 121.45% | 345.83% | |
69 Neutral | £237.92M | 49.01 | 12.29% | 0.95% | 22.72% | -8.82% | |
66 Neutral | £39.02M | 33.05 | 2.28% | 3.67% | -21.33% | -11.35% | |
65 Neutral | £229.91M | 61.54 | 3.13% | 2.19% | 10.66% | 21.19% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £213.67M | -3.05 | -31.42% | ― | -16.33% | -448.12% |